Abstract
Systemic sclerosis is a rare autoimmune condition affecting a variety of organ systems. Body surface involvement (of the integumentary system) leads to tightening of the skin involving the face and the intraoral tissues in both limited and diffuse cutaneous systemic sclerosis. Fibrosis of the orofacial complex results in a variety of oral complications including decreased oral aperture, muco-gingival defects, periodontal disease, dental caries, temporomandibular disorder (TMD), and trigeminal neuropathy. Xerostomia is also a common occurrence in these patients, related to medications and secondary Sjogren’s syndrome, among other causes. It is essential to be knowledgeable about the potential oral manifestations and the potential treatment options in this patient population. Due to the significant morbidity related to problems involving the mouth, as clinicians we must remain vigilant to our patients’ needs in this understudied area.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mayes MD, Reveille JD. Epidemiology, demographics and genetics. In: Clements PJ, Furst DE, eds. Systemic Sclerosis. 2nd ed. Philadelphia: Lippincott; 2004:1-15.
Vincent C, Agard C, Barbarot S, et al. Orofacial manifestations of systemic sclerosis: a study of 30 consecutive patients. Rev Méd Interne. 2009;30(1):5-11.
Porter SR, Scully C, Hegarty AM. An update of the etiology and management of xerostomia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;97(1):28-46.
Dawes C. Salivary flow patterns and the health of hard and soft oral tissues. J Am Dent Assoc. 2008;139(suppl):18S-24S.
Garcia-Godoy F, Hicks MJ. Maintaining the integrity of the enamel surface: the role of dental biofilm, saliva and preventive agents in enamel demineralization and remineralization. J Am Dent Assoc. 2008;139(suppl):25S-34S.
Hicks J, Garcia-Godoy F, Flaitz C. Biological factors in dental caries: role of saliva and dental plaque in the dynamic process of demineralization and remineralization (part 1). J Clin Pediatr Dent. 2003;28(1):47-52.
Bultzinglowen V. Salivary dysfunction associated with systemic diseases: systemic review and clinical management recommendations. Oral Surg Oral Med Oral Pathol. 2007;103(1):1-15.
Napenas JJ, Brennan MT, Fox PC. Diagnosis and treatment of xerostomia (dry mouth). Odontology. 2009;97(2):76-83.
Klasser GD, Balasubramaniam R, Epstein J. Topical review-connective tissue diseases: orofacial manifestations including pain. J Orofac Pain. 2007;21(3):171-184.
Guggenheimer J, Moore PA. Xerostomia: etiology, recognition and treatment. J Am Dent Assoc. 2003;134(1):61-69; quiz 118-119.
Greenberg M, Glick M. Immunologic diseases. In: Ciarroca K, Greenberg M, eds. Burket’s Oral Medicine. 10th ed. Hamilton: BC Decker; 2003:491-494.
Wood RE, Lee P. Analysis of the oral manifestations of systemic sclerosis (scleroderma). Oral Surg Oral Med Oral Pathol. 1988;65(2):172-178.
Scardina GA, Messina P. Systemic sclerosis: description and diagnostic role of the oral phenomena. Gen Dent. 2004;52(1):42-47.
Albilia JB, Lam DK, Blanas N, et al. Small mouths … Big problems? A review of scleroderma and its oral health implications. J Can Dent Assoc. 2007;73(9):831-836.
Garnett MJ, Nohl FS, Barclay SC. Management of patients with reduced oral aperture and mandibular hypomobility (trismus) and implications for operative dentistry. Br Dent J. 2008;204(3):125-131.
Samet N, Tau S, Findler M, et al. Flexible, removable partial denture for a patient with systemic sclerosis (scleroderma) and microstomia: a clinical report and a three-year follow-up. Gen Dent. 2007;55(6):548-551.
Oczakir C, Balmer S, Mericske-Stern R. Implant-prosthodontic treatment for special care patients: a case series study. Int J Prosthodont. 2005;18(5):383-389.
Patel K, Welfare R, Coonar HS. The provision of dental implants and a fixed prosthesis in the treatment of a patient with scleroderma: a clinical report. J Prosthet Dent. 1998;79(6):611-612.
Raviv E, Harel-Raviv M, Shatz P, et al. Implant-supported overdenture rehabilitation and progressive systemic sclerosis. Int J Prosthodont. 1996;9(5):440-444.
Weinlander M, Krennmair G, Piehslinger E. Implant prosthodontic rehabilitation of patients with rheumatic disorders: a case series report. Int J Prosthodont. 2010;23(1):22-28.
Esposito M, Thomsen P, Ericson LE, et al. Histopathologic observations on early oral implant failures. Int J Oral Maxillofac Implants. 1999;14(6):798-810.
Cartsos VM, Zhu S, Zavras AI. Bisphosphonate use and the risk of adverse jaw outcomes: a medical claims study of 714,217 people. J Am Dent Assoc. 2008;139(1):23-30.
Hwang D, Wang HL. Medical contraindications to implant therapy: part I: absolute contraindications. Implant Dent. 2006;15(4):353-360.
Hwang D, Wang HL. Medical contraindications to implant therapy: part II: relative contraindications. Implant Dent. 2007;16(1):13-23.
Elsubeihi ES, Zarb GA. Implant prosthodontics in medically challenged patients: the University of Toronto experience. J Can Dent Assoc. 2002;68(2):103-108.
Mealey BL. Periodontal implications: medically compromised patients. Ann Periodontol. 1996;1(1):256-321.
Jolly DE. Interpreting the clinical laboratory. J Calif Dent Assoc. 1995;23(11):32-40.
Javed F, Almas K. Osseointegration of dental implants in patients undergoing bisphosphonate treatment: a literature review. J Periodontol. 2010;81(4):479-484.
Khan AA, Sandor GK, Dore E, et al. Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw. J Rheumatol. 2008;35(7):1391-1397.
Lazarovici TS, Yahalom R, Taicher S, et al. Bisphosphonate-related osteonecrosis of the jaw associated with dental implants. J Oral Maxillofac Surg. 2010;68(4):790-796.
Madrid C, Sanz M. What impact do systemically administrated bisphosphonates have on oral implant therapy? A systematic review. Clin Oral Implants Res. 2009;20(suppl 4):87-95.
Neville B, Damm D, Allen C, et al. Dermatologic diseases. In: Oral and Maxillofacial Pathology. 1st ed. Philadelphia: Saunders; 1995:585-587.
Fox RI, Michelson PE. Head and neck involvement in systemic sclerosis. In: Clements PJ, Furst DE, eds. Systemic Sclerosis. 2nd ed. Philadelphia: Lippincott; 2004:151-161.
Weinstein WM, Kadell BM. The gastrointestinal tract in systemic sclerosis. In: Clements PJ, Furst DE, eds. Systemic Sclerosis. 2nd ed. Philadelphia: Lippincott; 2004:293-308.
Amaechi BT, Higham SM. Dental erosion: possible approaches to prevention and control. J Dent. 2005;33(3):243-252.
Almazrooa SA, Woo SB. Bisphosphonate and nonbisphosphonate-associated osteonecrosis of the jaw: a review. J Am Dent Assoc. 2009;140(7):864-875.
Edwards BJ, Migliorati CA. Osteoporosis and its implications for dental patients. J Am Dent Assoc. 2008;139(5):545-552; quiz 625–626.
Nadeau SE. Neurologic manifestations of connective tissue disease. Neurol Clin. 2002;20(1):151-178; vi.
Farrell DA, Medsger TA Jr. Trigeminal neuropathy in progressive systemic sclerosis. Am J Med. 1982;73(1):57-62.
Fischoff DK, Sirois D. Painful trigeminal neuropathy caused by severe mandibular resorption and nerve compression in a patient with systemic sclerosis: case report and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;90(4):456-459.
Hietarinta M, Lassila O, Hietaharju A. Association of anti-U1RNP- and anti-Scl-70-antibodies with neurological manifestations in systemic sclerosis (scleroderma). Scand J Rheumatol. 1994;23(2):64-67.
Nascimento IS, Bonfa E, de Carvalho JF, et al. Clues for previously undiagnosed connective tissue disease in patients with trigeminal neuralgia. J Clin Rheumatol. 2010;16(5):205-208.
Derk CT, Rasheed M, Spiegel JR, et al. Increased incidence of carcinoma of the tongue in patients with systemic sclerosis. J Rheumatol. 2005;32(4):637-641.
Marcucci M, Abdala N. Clinical and radiographic study of orofacial alterations in patients with systemic sclerosis. Braz Oral Res. 2009;23(1):82-88.
Marcucci M, Abdala N. Analysis of the masseter muscle in patients with systemic sclerosis: a study by magnetic resonance imaging. Dentomaxillofac Radiol. 2009;38(8):524-530.
Jackowski J, Johren P, Muller AM, et al. Imaging of fibrosis of the oral mucosa by 20 MHz sonography. Dentomaxillofac Radiol. 1999;28(5):290-294.
Tolle SL. Scleroderma: considerations for dental hygienists. Int J Dent Hyg. 2008;6(2):77-83.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag London Limited
About this chapter
Cite this chapter
Hant, F.N., Ravenel, M.C. (2011). A Dentist Inquires About His Patient with Systemic Sclerosis. In: Silver, R., Denton, C. (eds) Case Studies in Systemic Sclerosis. Springer, London. https://doi.org/10.1007/978-0-85729-641-2_32
Download citation
DOI: https://doi.org/10.1007/978-0-85729-641-2_32
Published:
Publisher Name: Springer, London
Print ISBN: 978-0-85729-640-5
Online ISBN: 978-0-85729-641-2
eBook Packages: MedicineMedicine (R0)